High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.
作者信息
Gazzaruso Carmine, Carlo Stella Nicoletta, Mariani Giuseppe, Nai Carlo, Coppola Adriana, Naldani Daniela, Gallotti Pietro
机构信息
Emergency Unit and Endocrinology Unit, Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Corso Pavia, 84, 27029, Vigevano, Italy.
Centre for Applied Clinical Research (Ce.R.C.A.), Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Vigevano, Italy.
出版信息
Clin Rheumatol. 2020 Jul;39(7):2095-2097. doi: 10.1007/s10067-020-05180-7. Epub 2020 May 27.
Abstract
摘要
相似文献
1
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.
Clin Rheumatol. 2020 Jul;39(7):2095-2097. doi: 10.1007/s10067-020-05180-7. Epub 2020 May 27.
2
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.
J Thromb Thrombolysis. 2021 May;51(4):1111-1112. doi: 10.1007/s11239-020-02115-6.
3
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
4
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).
JAMA Netw Open. 2020 Aug 3;3(8):e2017539. doi: 10.1001/jamanetworkopen.2020.17539.
5
Lupus anticoagulant in patients with COVID-19.
Int J Lab Hematol. 2021 Feb;43(1):e17-e18. doi: 10.1111/ijlh.13334. Epub 2020 Sep 11.
6
A 31-Year-Old Man with COVID-19-Associated Empyema and Lupus Anticoagulant.
Am J Case Rep. 2020 Aug 18;21:e926623. doi: 10.12659/AJCR.926623.
7
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020.
PLoS One. 2020 Oct 29;15(10):e0236905. doi: 10.1371/journal.pone.0236905. eCollection 2020.
8
Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?
Clin Exp Rheumatol. 2020 May-Jun;38(3):577. Epub 2020 May 27.
9
[First results of investigations of SARS-CoV‑2 RNA in human corneal tissue].
Ophthalmologe. 2020 Jul;117(7):615-617. doi: 10.1007/s00347-020-01151-0.
10
Retinal involvement and ocular findings in COVID-19 pneumonia patients.
Sci Rep. 2020 Oct 15;10(1):17419. doi: 10.1038/s41598-020-74446-6.
引用本文的文献
1
Antiphospholipid antibodies in patients with COVID-19: a systematic review and meta-analysis.
J Thromb Thrombolysis. 2025 Jul 5. doi: 10.1007/s11239-025-03116-z.
2
The New Occurrence of Antiphospholipid Syndrome in Severe COVID-19 Cases with Pneumonia and Vascular Thrombosis Could Explain the Post-COVID Syndrome.
Biomedicines. 2025 Feb 19;13(2):516. doi: 10.3390/biomedicines13020516.
3
Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection.
FASEB J. 2025 Feb 28;39(4):e70390. doi: 10.1096/fj.202402694R.
4
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.
Front Immunol. 2025 Jan 6;15:1509289. doi: 10.3389/fimmu.2024.1509289. eCollection 2024.
5
The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature.
Thromb J. 2024 Nov 8;22(1):99. doi: 10.1186/s12959-024-00669-6.
6
Demyelination in Patients with POST-COVID Depression.
J Clin Med. 2024 Aug 9;13(16):4692. doi: 10.3390/jcm13164692.
7
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review.
Am J Med Open. 2024 Feb 14;11:100068. doi: 10.1016/j.ajmo.2024.100068. eCollection 2024 Jun.
8
The correlation between corona virus disease 2019 and alopecia areata: a literature review.
Front Immunol. 2024 Jul 3;15:1347311. doi: 10.3389/fimmu.2024.1347311. eCollection 2024.
9
Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit.
Int J Mol Sci. 2024 Jul 2;25(13):7273. doi: 10.3390/ijms25137273.
10
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study.
Biomedicines. 2024 Jun 13;12(6):1306. doi: 10.3390/biomedicines12061306.
本文引用的文献
1
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review.
Int J Environ Res Public Health. 2020 Apr 14;17(8):2690. doi: 10.3390/ijerph17082690.
2
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
3
Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms.
Viruses. 2019 Aug 19;11(8):762. doi: 10.3390/v11080762.
Zotero 插件